ARYEX | CSEIX | ARYEX / CSEIX | |
Total Expense Ratio | 0.80 | 1.10 | 73% |
Annual Report Gross Expense Ratio | 0.80 | 1.10 | 73% |
Fund Existence | 9 years | 28 years | - |
Gain YTD | 1.646 | 4.263 | 39% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 541M | 8.35B | 6% |
Annual Yield % from dividends | 2.48 | 2.72 | 91% |
Returns for 1 year | -1.87 | -1.84 | 102% |
Returns for 3 years | 22.30 | 32.55 | 68% |
Returns for 5 years | 11.46 | 27.20 | 42% |
Returns for 10 years | N/A | 55.25 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NESNX | 65.87 | 0.10 | +0.15% |
Natixis US Equity Opportunities N | |||
VMCIX | 80.36 | N/A | N/A |
Vanguard Mid Cap Index Institutional | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C | |||
BGLCX | 14.70 | N/A | N/A |
Brookfield Global Listed InfrastructureC | |||
BRWJX | 29.31 | N/A | N/A |
MFS Blended Research Growth Eq I |